Serge Saxonov is the Co-Founder and CEO of 10x Genomics, a position he has held since 2012. He is a proponent of technology and innovation as drivers for improving the world, particularly emphasizing the transformative potential of advances in the life sciences.
Prior to co-founding 10x Genomics, Saxonov served as VP Applications at QuantaLife from May 2010 to April 2012. QuantaLife was acquired by Bio-Rad in 2011.